MedPath
Found 1 clinical trials|View Analysis
Sort by:

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

Phase 2
Completed
Conditions
Frailty
Sarcopenia
Aging
Interventions
Drug: placebo 600mg
Drug: MYMD-1 1050mg
Drug: MYMD-1 600MG
Drug: MYMD-1 750mg
Drug: placebo 900mg
Drug: placebo 750mg
Drug: placebo 1050mg
Drug: MYMD-1 900mg
First Posted Date
2022-03-17
Last Posted Date
2023-10-30
Lead Sponsor
MyMD Pharmaceuticals, Inc.
Target Recruit Count
40
Registration Number
NCT05283486
Locations
🇺🇸

Clinical Research of West Florida, Inc, Clearwater, Florida, United States

🇺🇸

Clinical Research of West Florida, Tampa, Florida, United States

🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath